Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Centogene n.v. crawled time : 11:00 save search
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 1.43%
H: 1.41%
C: -1.41%
partnership genetic takeda disorders
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
Published: 2023-10-10 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -0.68%
H: 1.66%
C: 1.66%
diagnostic offering
CENTOGENE to Participate in Upcoming Conferences in August
Published: 2023-08-07 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -2.91%
H: 2.0%
C: 0.0%
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
Published: 2023-07-14 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 1.35%
H: 4.0%
C: -2.0%
nasdaq
CENTOGENE to Participate in Upcoming Conferences in May
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -3.0%
H: 3.01%
C: -0.81%
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
Published: 2023-04-12 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 13.02%
H: 7.33%
C: -7.48%
centogenome rare solution neurodegenerative
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2023-04-11 (Crawled : 11:00) - globenewswire.com
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
|
| O: -0.36%
H: 0.35%
C: -0.12%
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 12.46%
H: 0.0%
C: -11.04%
partnership genetic
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
Published: 2022-11-03 (Crawled : 11:00) - biospace.com/
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -0.01%
H: 2.14%
C: 2.14%
rare disease neurodegenerative
CENTOGENE to Participate in Upcoming Partnering Conferences in October 2022
Published: 2022-10-06 (Crawled : 11:00) - biospace.com/
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 0.0%
H: 2.68%
C: 2.68%
Outlook on the Hereditary Angioedema Global Market to 2030 - Size, Share, Outlook, and Opportunity Analysis
Published: 2022-09-05 (Crawled : 11:00) - prnewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
| Email alert
Add to watchlist
ADVM | $11.55 -1.54% -1.56% 99K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.9 -2.18% 880
|
Health Technology
| Email alert
Add to watchlist
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
| Email alert
Add to watchlist
IONS | $41.56 -0.43% -0.43% 760K
|
Health Technology
| Email alert
Add to watchlist
BCRX | $4.68 -1.89% -1.92% 2.5M
|
Health Technology
| Email alert
Add to watchlist
ARWR | $24.02 -2.75% -2.83% 880K
|
Health Technology
| Email alert
Add to watchlist
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
| Email alert
Add to watchlist
global market hereditary angioedema
CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September
Published: 2022-09-01 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -4.11%
H: 1.07%
C: -13.57%
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.64 0.09% 0.0% 700K
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $39.67 -1.27% 0.0% 550K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH | $203.32 -1.17% 0.0% 670K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $140.22 -0.36% 0.0% 1.5M
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $19.36 -4.3% -4.49% 830K
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $39.67 -1.27% 0.0% 550K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.245 1.22% 1.2% 3.7M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $121.18 -4.64% -4.86% 1.6M
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease
Published: 2022-06-13 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -4.21%
H: 4.39%
C: 3.52%
AGIO | $29.29 -0.75% -0.75% 620K
|
Health Technology
|
| O: -6.12%
H: 2.7%
C: -2.36%
pyrukynd partnership blood rare disease children
CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework
Published: 2022-05-25 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 0.55%
H: 0.56%
C: -0.92%
centocloud one
CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics
Published: 2022-05-23 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 2.29%
H: 0.0%
C: -1.56%
guidelines rare disease diagnostics diagnostic
CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022
Published: 2022-03-23 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -0.95%
H: 4.78%
C: -1.91%
results
CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
Published: 2022-03-17 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -0.8%
H: 12.83%
C: 6.95%
expansion collaboration
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases
Published: 2021-11-04 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 2.94%
H: 1.83%
C: -0.92%
AGIO | $29.29 -0.75% -0.75% 620K
|
Health Technology
|
| O: 6.36%
H: 1.98%
C: -7.64%
disease partnership blood rare
CENTOGENE Reports Second Quarter 2021 Financial Results
Published: 2021-09-07 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: 6.75%
H: 0.0%
C: -6.68%
financial results results
CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021
Published: 2021-09-01 (Crawled : 11:00) - globenewswire.com
CNTG | $0.5555 -11.21% 87K
|
Commercial Services
|
| O: -1.69%
H: 2.53%
C: -1.07%
financial results results
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.